These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19195112)

  • 1. The rapidly evolving diagnosis and treatment of age-related macular degeneration.
    Optometry; 2009 Feb; 80(2):101-6. PubMed ID: 19195112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related macular degeneration: a practical approach to a challenging disease.
    Bourla DH; Young TA
    J Am Geriatr Soc; 2006 Jul; 54(7):1130-5. PubMed ID: 16866687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of treatment of age-related macular degeneration: a review.
    Kymes Steven M
    Minerva Med; 2009 Feb; 100(1):69-78. PubMed ID: 19277005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging therapies for neovascular age-related macular degeneration: state of the art.
    Donati G
    Ophthalmologica; 2007; 221(6):366-77. PubMed ID: 17947822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macular degeneration. An age-related cause of vision loss.
    Mayo Clin Womens Healthsource; 2009 Mar; 13(3):1-2. PubMed ID: 19179929
    [No Abstract]   [Full Text] [Related]  

  • 6. Age-related macular degeneration: update for primary care.
    Fong DS
    Am Fam Physician; 2000 May; 61(10):3035-42. PubMed ID: 10839553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Status of low-vision rehabilitation for age-related macular degeneration by orthoptists in the North of France].
    Desmettre T; Hladiuk K; Bourgois S; Boursier C; Calmet X; Duquesne P; Pinoche B; Razemon P; Rossi C; Ryckewaert M; Hecquet B
    J Fr Ophtalmol; 2003 Mar; 26(3):241-8. PubMed ID: 12746599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No efficacious treatment for age-related macular degeneration.
    Roodhooft J
    Bull Soc Belge Ophtalmol; 2000; 276():83-92. PubMed ID: 10925530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New evidence that vision rehabilitation is a key component in the management of patients with macular degeneration.
    Edmonds SA; Edmonds SE
    Curr Opin Ophthalmol; 2006 Jun; 17(3):278-80. PubMed ID: 16794441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related macular degeneration: diagnosis and management.
    Cook HL; Patel PJ; Tufail A
    Br Med Bull; 2008; 85():127-49. PubMed ID: 18334518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-Related Macular Degeneration.
    Mehta S
    Prim Care; 2015 Sep; 42(3):377-91. PubMed ID: 26319344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Age-related macular degeneration].
    Seland JH
    Tidsskr Nor Laegeforen; 2004 Jan; 124(1):52-4. PubMed ID: 14716396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of age-related macular degeneration.
    Mohan KC; Shukla D; Namperumalsamy P; Kim R
    J Indian Med Assoc; 2003 Aug; 101(8):471-4, 476. PubMed ID: 15071799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related macular degeneration.
    Brucker AJ
    Retina; 2009 Jun; 29(6 Suppl):S2-4. PubMed ID: 19553791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual prosthetic device for bilateral end-stage macular degeneration.
    Chun DW; Heier JS; Raizman MB
    Expert Rev Med Devices; 2005 Nov; 2(6):657-65. PubMed ID: 16293092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related macular degeneration: an update on treatment.
    Gohel PS; Mandava N; Olson JL; Durairaj VD
    Am J Med; 2008 Apr; 121(4):279-81. PubMed ID: 18374683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic approaches to age-related macular degeneration today.
    Bressler NM
    Ophthalmology; 2009 Oct; 116(10 Suppl):S15-23. PubMed ID: 19800535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for inhibiting vascular endothelial growth factor.
    Kaiser PK
    Retina; 2009 Jun; 29(6 Suppl):S15-7. PubMed ID: 19553789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost of vision for vitreoretinal interventions.
    Smiddy WE
    Curr Opin Ophthalmol; 2008 May; 19(3):195-201. PubMed ID: 18408493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration.
    Sayanagi K; Sharma S; Kaiser PK
    Br J Ophthalmol; 2009 May; 93(5):622-6. PubMed ID: 19208677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.